Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

400 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels.
Piatti PM, Monti LD, Pacchioni M, Pontiroli AE, Pozza G. Piatti PM, et al. Among authors: pozza g. Metabolism. 1991 Sep;40(9):926-33. doi: 10.1016/0026-0495(91)90068-8. Metabolism. 1991. PMID: 1895958 Clinical Trial.
Insulin sensitivity and lipid levels in obese subjects after slimming diets with different complex and simple carbohydrate content.
Piatti PM, Pontiroli AE, Saibene A, Santambrogio G, Paroni R, Magni F, Galli-Kienle M, Mistrali S, Monti LD, Pozza G. Piatti PM, et al. Among authors: pozza g. Int J Obes Relat Metab Disord. 1993 Jul;17(7):375-81. Int J Obes Relat Metab Disord. 1993. PMID: 8395472 Clinical Trial.
Spontaneous hypoglycaemia after pancreas transplantation in Type 1 diabetes mellitus.
Battezzati A, Bonfatti D, Benedini S, Calori G, Caldara R, Mazzaferro V, Elli A, Secchi A, Di Carlo V, Pozza G, Luzi L. Battezzati A, et al. Among authors: pozza g. Diabet Med. 1998 Dec;15(12):991-6. doi: 10.1002/(SICI)1096-9136(1998120)15:12<991::AID-DIA717>3.0.CO;2-Q. Diabet Med. 1998. PMID: 9868970
Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
Piatti PM, Monti LD, Davis SN, Conti M, Brown MD, Pozza G, Alberti KG. Piatti PM, et al. Among authors: pozza g. Diabetologia. 1996 Jan;39(1):103-12. doi: 10.1007/BF00400420. Diabetologia. 1996. PMID: 8720610 Clinical Trial.
Two 75-g oral glucose tolerance tests were performed in random order. Placebo or 250 mg acipimox (to inhibit lipolysis) were administered orally 2 h before the start of the oral glucose tolerance test. ...
Two 75-g oral glucose tolerance tests were performed in random order. Placebo or 250 mg acipimox (to inhibit lipolysis) were administ …
First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation.
Secchi A, Martinenghi S, Caldara R, La Rocca E, Di Carlo V, Pozza G. Secchi A, et al. Among authors: pozza g. Diabetologia. 1991 Aug;34 Suppl 1:S53-6. doi: 10.1007/BF00587620. Diabetologia. 1991. PMID: 1936696
Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Martina V, Pontiroli AE, Tagliabue M, Calderara A, Maccario M, Pacchioni M, Bertaina S, Bruno G, Pozza G, Camanni F. Martina V, et al. Among authors: pozza g. Horm Metab Res. 1994 Mar;26(3):148-51. doi: 10.1055/s-2007-1000797. Horm Metab Res. 1994. PMID: 8005563 Clinical Trial.
Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
Fragasso G, Piatti PM, Monti L, Palloshi A, Lu C, Valsecchi G, Setola E, Calori G, Pozza G, Margonato A, Chierchia S. Fragasso G, et al. Among authors: pozza g. J Am Coll Cardiol. 2002 Feb 6;39(3):413-9. doi: 10.1016/s0735-1097(01)01768-5. J Am Coll Cardiol. 2002. PMID: 11823078 Clinical Trial.
Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
Piatti P, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, Paroni R, Galluccio E, Pozza G, Chierchia S, Margonato A. Piatti P, et al. Among authors: pozza g. Circulation. 2003 Jan 28;107(3):429-36. doi: 10.1161/01.cir.0000046489.24563.79. Circulation. 2003. PMID: 12551867 Clinical Trial.
METHODS AND RESULTS: Nine patients with CSX and 14 control subjects underwent a continuous infusion of L-arginine (0.125 g/min) or saline for 120 minutes. ...
METHODS AND RESULTS: Nine patients with CSX and 14 control subjects underwent a continuous infusion of L-arginine (0.125 g/min) or sa …
Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients.
Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti KG. Piatti PM, et al. Among authors: pozza g. Diabetes Care. 2001 May;24(5):875-80. doi: 10.2337/diacare.24.5.875. Diabetes Care. 2001. PMID: 11347747 Clinical Trial.
In group 2 patients were treated for 1 month with diet plus placebo orally, three times per day) and then for 1 month with diet plus L-arginine (3 g three times per day). ...
In group 2 patients were treated for 1 month with diet plus placebo orally, three times per day) and then for 1 month with diet plus L-argin …
Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans.
Piatti PM, Monti LD, Conti M, Baruffaldi L, Galli L, Phan CV, Guazzini B, Pontiroli AE, Pozza G. Piatti PM, et al. Among authors: pozza g. Diabetes. 1996 Mar;45(3):316-21. doi: 10.2337/diab.45.3.316. Diabetes. 1996. PMID: 8593936
400 results
Jump to page
Feedback